Squar Milner Financial Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,406
Closed -$66K 409
2020
Q1
$66K Buy
1,406
+212
+18% +$11.3K 0.04% 337
2019
Q4
$70K Buy
+1,194
New +$66.4K 0.04% 381
2019
Q3
Sell
-1,312
Closed -$66K 410
2019
Q2
$66K Buy
1,312
+134
+11% +$6.72K 0.04% 318
2019
Q1
$61K Buy
1,178
+166
+16% +$8.29K 0.05% 306
2018
Q4
$48K Buy
1,012
+800
+377% +$39.4K 0.05% 295
2018
Q3
$11K Sell
212
-145
-41% -$7.37K 0.01% 476
2018
Q2
$18K Buy
+357
New +$18K 0.02% 497

Other funds holding GSK

Squar Milner Financial Services's GSK Position: Q2 2020 in Review

Squar Milner Financial Services sold out of GSK (GSK) in Q2 2020, closing a stake of 1,406 shares — an estimated $66K sold.

Squar Milner Financial Services first reported a position in GSK in Q2 2018 and held it in 7 quarters. The position peaked at $70K in Q4 2019. 841 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Squar Milner Financial Services reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 1,406 GSK shares in Q2 2020, an estimated $66K.
  • Squar Milner Financial Services first reported a position in GSK in Q2 2018 and held it in 7 quarters.
  • Squar Milner Financial Services's GSK position peaked at $70K in Q4 2019.
  • 841 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.